Sales and Marketing

Showing 15 posts of 11524 posts found.

heart_money

Heart failure market to quadruple in ten years to $16 billion

July 6, 2017 Sales and Marketing GlobalData, Novartis, heart failure

New research from intelligence firm GlobalData has indicated that the market for heart failure drugs is forecast to expand by …

Merck Foundation created and CEO set in place

July 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Foundation, Merck KGaA

Merck KGaA announced that is has created the Merck Foundation and has appointed Rasha Kelej as its CEO. The role …
eu_and_fda

EMA and FDA harmonise over development of Gaucher drugs

July 5, 2017 Medical Communications, Research and Development, Sales and Marketing EMA, FDA, Gaucher disease

The EMA and the FDA have announced that they have developed a joint proposal to promote more efficient means of …

NICE agrees approval deal for ultra-rare juvenile bone disease

July 5, 2017 Research and Development, Sales and Marketing Alexion, NICE, Strensiq

NICE has announced that it has decided to approve Alexion Pharma’s Strensiq (asfotase alfa) for the treatment of ultra-rare disease …
new_wave_logo_cmyk

Gain insight into what your peers are doing

July 5, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, wave

When they first came along, webinars were the equivalent of an outside broadcast unit, lots of hardware, dedicated studios and …

Stada CEO and CFO tumble in takeover turmoil

July 4, 2017 Sales and Marketing Bain capital, Cinven, Stada

Stada, the German generic drugs manufacturer, saw its two most senior executives leave the company for ‘personal reasons’. Matthias Wiedenfels, …

Johnson & Johnson face major lawsuit over vaginal mesh

July 4, 2017 Manufacturing and Production, Sales and Marketing J&J, JJ, Johnson & Johnson, lawsuit, vaginal mesh

Johnson & Johnson will face a lawsuit after 700 Australian women launched a class action suit over the failures of …
astrazeneca_building_white

AstraZeneca generates $600 million from just two drug sales

July 3, 2017 Manufacturing and Production, Sales and Marketing AstraZeneca, Seloken, Zomig

AstraZeneca is expected to generate almost $600 million from just two drug sales: Zoming, a migraine therapy, and Seloken, a …

Forging a path forward in neurological disorders

July 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing neurological disorders

The development of innovative treatments for neurological disorders such as dementia has stagnated over the past decade despite being an …
index_ph001

Big success and even bigger failure for Daiichi Sankyo’s experimental therapy

July 3, 2017 Research and Development, Sales and Marketing Daiichi Sankyo, mirogabalin

Daiichi Sankyo has been hit with mixed news this week regarding its experimental therapy mirogabalin. The drug posted trial success …
gsk_boronia_australia

GSK signs $43 million AI-based drug discovery deal with Exscientia

July 3, 2017 Research and Development, Sales and Marketing AstraZeneca, Exscientia, GSK

With AI partnerships becoming increasingly common in the life sciences industry, it has emerged that GSK is to partner up …
astrazeneca_sign_sky

New Pfizer EU approval offers first treatment option for leukaemia subtype

July 3, 2017 Sales and Marketing AstraZeneca, Besponsa, EU, European Commission

Pfizer has revealed that its drug Besponsa (inotuzumab ozogamicin) has received approval from the European Commission as a monotherapy for …

NICE recommends AstraZeneca lung treatment

July 3, 2017 Sales and Marketing AstraZeneca, Daxas, NICE

AstraZeneca’s Daxas (roflumilast) has received recommendation from NICE for the treatment of chronic obstructive pulmonary disease (COPD) it has emerged, …
The Gateway to Local Adoption Series

Latest content